Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1981 Dec;12(6):883-6.
doi: 10.1111/j.1365-2125.1981.tb01325.x.

Indapamide and bendrofluazide: a comparison in the management of essential hypertension

R F Bing, G I Russell, J D Swales, H Thurston
Clinical Trial

Indapamide and bendrofluazide: a comparison in the management of essential hypertension

R F Bing et al. Br J Clin Pharmacol. 1981 Dec.

Abstract

1 To compare the efficacy of indapamide with that of bendrofluazide a randomised trial was carried out in twenty patients with essential hypertension. 2 Indapamide (2.5 mg a day) and bendrofluazide (5 mg a day) produced a significant but equivalent fall in blood pressure. 3 Both drugs caused a reduction in body weight and serum potassium with a rise in plasma renin activity but there were no other major side effects. 4 In twelve patients treated with a combination of indapamide and bendrofluazide there was no additional fall in mean blood pressure or serum potassium compared to treatment with bendrofluazide or indapamide alone.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Annu Rev Pharmacol. 1967;7:399-408 - PubMed
    1. Circulation. 1970 Sep;42(3):479-85 - PubMed
    1. J Cardiovasc Pharmacol. 1979 Jul-Aug;1(4):389-94 - PubMed
    1. Circ Res. 1978 Mar;42(3):376-81 - PubMed
    1. Lancet. 1979 Jul 21;2(8134):121-3 - PubMed